Ali Khavari, DPM
Foot & Ankle Surgery · Walnut Creek, CANPI 1043836778
Payments from drug & device makers
Across 32 payments — averaging $90.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Kerecis Limited$450
- Mimedx Group, Inc.$209
- Bioventus LLC$178
- Smith+Nephew$162
- Johnson & Johnson$113
- plus $332 from 6 others
What the payments were for
- Travel & lodging$92832%
- Food & beverage$1,95468%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 8 | $1,438 |
| Kerecis Limited | 5 | $450 |
| Mimedx Group, Inc. | 6 | $209 |
| Bioventus LLC | 1 | $178 |
| Smith+Nephew | 2 | $162 |
| Johnson & Johnson | 1 | $113 |
| Stryker | 3 | $105 |
| Bone Support Inc. | 1 | $81 |
| Evolution Surgical, Inc | 2 | $48 |
| Averitas Pharma Inc. | 1 | $39 |
| Orthofix Medical, Inc. | 1 | $33 |
| Solventum Corporation | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$994
- Portfolio$533
- Bun-Yo-Matic$516
- Kerecis Omega3 SurgiClose$249
- Exogen Ultrasound Bone Healing System$178
- GRAFIX PL$132
- Stravix$132
- STRAVIX PL$132
- Phantom Fibula Nail$118
- MOTOBAND$113
How this compares
$2,881 in reported general payments places this provider in the 55th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 22 | $18 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Walnut Creek
- John ZimmermanBakersfield$4.6M
- Eric GizaSacramento$3.7M
- Thomas HarrisPasadena$3M
- Felix SigalLos Angeles$2.2M
- Thomas ChangSanta Rosa$2.1M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.